We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Real Hotel Grp | RHG | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.875 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.875 | 1.875 |
| Top Posts |
|---|
Posted at 24/11/2005 12:00 by schober A comparison!AHCI RHG Mcap £156m £19m TO £212m £90m Eps 2005 23.8p 2006 28p +17% at same mc/to ratio => rhg mcap of £66m or 200p a share but a lot of rhg is lower margin work |
Posted at 24/11/2005 11:58 by schober A comparison!AHCI RHG Mcap £156m £19m TO £212m £90m Eps2005 23.8p 2006 28p +17% at same mc/to ratio => rhg mcap of £66m or 200p a share but a lot of rhg is lower margin work |
Posted at 22/3/2005 09:52 by schober looks like we'll have to trust trevor and angela to turn things round!Board changes 01/12/2004 Following a meeting of the Board held on 25 November 2004, Reed Health Group has announced that Trevor Goul-Wheeker has been appointed as Chief Executive Officer of the Company with effect from 7 December 2004. Trevor Goul-Wheeker is a highly experienced Chief Executive and is currently Executive Director at WHSmith. Previously, he was Non-Executive Chairman of Knowledge Support Systems plc, where he was instrumental in returning cash to shareholders, and Managing Director, Hammicks Bookshops Ltd, which was sold in 2003 following a major turnaround programme. His career also has encompassed a number of senior executive positions in Gestetner and Unilever, where Trevor ran both UK and International Divisions with significant sales into the health, education and institutional sectors. Reed Health Group has also announced that Angela Morris has been appointed as a Director of the Company at the Board meeting held today. Angela is currently Divisional Director, Reed Nurse and Social Care. She joined Reed Health Group in October 2002 as operations director of Reed Social Care, taking over the additional responsibility for Reed Nurse in April 2004. Angela Morris has worked in health and social care recruitment since 1988. She accepted her first Director’s appointment in 1997 for the social care and pharmacy divisions of CSG Healthcare where she stayed until 2000. During 2000, she completed a venture capital backed, £27m leveraged management buy-in acquiring two separate companies to form Corinth Healthcare, a healthcare recruitment company. ....not forgetting the new it system (it does sound quite good!) Reed Health Group Launches Interactive Financial Management Information System 10/02/2005 09:59:00 Reed Health Group, the provider of staffing services in the Health, Social Care and Education sectors in the UK, has today launched RHG Interactive ("RHGi"), a financial management information system, which is expected to revolutionise the way the Company works with its clients. This technology platform has been designed to provide Reed Health Group’s clients with the ability to maximise efficiency, reduce costs and streamline their staffing agency invoice processes. In response to clients concerns over costs, in terms of time and money, Reed Health Group conducted extensive research into the issues behind the management of high volumes of agency staffing invoices. Following an investment of £3 million, the Company has been able to create one of the most technically advanced financial management information systems in the market place............... |
Posted at 28/2/2005 09:07 by salpara111 I guess the only consistent thing about RHG is its ability to issue profits warnings.I had watched since the last bounce to 50 but was not convinced, then I was kicking myself that I hadnt got in when it reached 70 but now back where it started. I guess the bigger question is where will it go from here. I cant see people rushing back in again only to get stung again. |
Posted at 10/10/2004 16:47 by ok,yah ForecastsYear Ending EPS P/E PEG EPS Growth Dividend Dividend Yield 30-06-2005 9.00p 6.06 0.09 +66.67% 2.60p 4.95% |
Posted at 07/10/2004 11:36 by ok,yah Back in this am - bullish statement and great dividend at this price. Should make 4m - 6m profit this year. Worth about £1.00 on fundamentals |
Posted at 26/2/2004 21:44 by jpmorgan Have reviewed the interim results this evening. I have tried to group quantative/qualatatiSummary thoughts are below: (1)Reed Executive takes over RHG in next half year and takes advantage of scenario 2 buying an earning enhancing propostion. (2)The increase in senior management, integrated IT, and increased branches is laying foundation for a solid £6m profits profile (with associated cash flow) from July 04 onwards. Current market value is c£30m with no long term debt. Issues related to PASA etc should have been mitigated by this point. (3)A potential worst case scenario looking forward is that RHG is now in a commodity marketplace in 2 divisions. Thus RHG is currently unable to leverage profits effectively on large turnover due to intense competition and smarter working by the NHS. Thus profits will remain static under 5m for short to medium term. Cannot clearly get a view on whether scenario 2 or 3 or mix is likely. With real cash inflow continuing and markets growing I will wait till full year results before choosing to sell or remain long term holder. Any thoughts on RHG by BB? JPM |
Posted at 20/2/2004 12:24 by jpmorgan Schober,My research file shows: Reed Family Interests Own: 38.3% Schroders: 26% Other: No major shareholders This may have changed will check sources at interims. Due to relative small size of company there is limited coverage and knowledge by analysts/press which means could get RHG at a good price. As AR has such large holding it would be very difficult for any other company to bid. Guess it would come down to current management at RHG who have basically been appointed by AReed. Best wait for the results to assess the numbers to see if there is still value being added to the company. JPM. |
Posted at 20/2/2004 12:08 by schober suspect that a reed might find it harder to buy back rhg than he did reed executive - do we know the % of instituional shareholders? |
Posted at 27/9/2003 10:53 by jpmorgan Have reviewed the results. Overall am pleased. Some highlights include:Positive ======== >Decent profit margin (6.8%) and net cash inflow of 8.8m >Lord Sawyer remaining as non-exec director >5.5 million operating profit >Increasing dividend which can be sustained >Health markets still active/growing (as opposed to IT recruitment!) Neutral ======= >The takeover of Locum by RHG has really become a reverse takeover with both Chairman, and Chief Exec from Locum. I do not consider this a pure negative currently, as results appear positive, and Locum had a good record of growth. Negative ======== >NHS professionals looks like it will succeed, which in the long term could cap profit margins and growth for nursing. The concept in the longer run could be applied to all professionals though think this unlikely. >Increasing net administrative costs, and lots of new director level staff which if cannot add value I consider a negative. Prospects for next financial year appear positive as the marketplace for RHG sectors are still active. Nestor statements support this view also. This marketplace should help support operating profits growth by 15-20% towards 6.5+ million no debt, and increased shareholder funds. Current market valuation of 36million. A famous saying by Benjamin Graham, is "in the short run, the market is a voting machine, and in the long run a weighing machine". Sentiment is still against RHG due to poor practice by Alec Reed last year, but the business in the big picture is growing in a growing marketplace with experienced management. If Alec Reed does not bag a bargain with takeover, results will rerate the share to a more respectable level over time. All IMHO. JPM. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
